STING1 and neoplasm: With intracytoplasmic DNA, cGAS-STING agonist can increase the production of interleukin 6 (IL-6), tumor necrosis factor (TNF) and interferon (IFN) [19] and play a regulatory role in inflammation and tumor treatment [20,21,22].